D-0233-2022 Class II Terminated
FDA drug recall D-0233-2022 was initiated by Amneal Pharmaceuticals Of New York, LLC on Nov 4, 2021 and is designated Class II. Reason for recall: Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide. The recall status is terminated (terminated Jun 9, 2022). Affected quantity: 7,766 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 24, 2021
- Initiation Date
- Nov 4, 2021
- Termination Date
- Jun 9, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,766 bottles
Product description
Flocinolone Acetonide 0.01% Topical Oil, Body Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceuticals Bridgewater, NJ 08807, NDC 65162-704-86
Reason for recall
Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.
Distribution pattern
Product was distributed nationwide within the United States
Code information
Lot #: 07040001A, exp. date 02/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0233-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026